A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)

Investigator(s):
Daniel C. Lu, M.D., Ph.D.;
Organization: 
UCLA
NCT Number: 
Disease Name: 
Traumatic Brain Injury
Disease Category: 
Trial Phases: 
Phase 2
Trial Status: 
Active, Not Recruiting
Trial Contact: 

Courtney Real, RN 
(310) 267-7433 
creal@mednet.ucla.edu